Linked Life Data

17908524

Source:http://linkedlifedata.com/resource/pubmed/id/17908524

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2007-10-2
pubmed:abstractText
To determine the long-term effects of a combined regimen of lenalidomide and dexamethasone (Rev-Dex) on time to progression, progression-free survival, and overall survival (OS) in patients with multiple myeloma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0025-6196
pubmed:author
pubmed:issnType
Print
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1179-84
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
pubmed:affiliation
Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. lacy.martha@mayo.edu
pubmed:publicationType
Journal Article